WH
Therapeutic Areas
Ridgeback Biotherapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| EBANGA™ (Ansuvimab-zykl) | Ebola Virus Disease (Zaire ebolavirus) | Approved |
| Lagevrio (molnupiravir) | COVID-19 | Approved/EUA |
| Drug | Indication | Phase |
|---|---|---|
| EBANGA™ (Ansuvimab-zykl) | Ebola Virus Disease (Zaire ebolavirus) | Approved |
| Lagevrio (molnupiravir) | COVID-19 | Approved/EUA |